
- Volume 0 0
Flexbumin [Albumin (Human)] 25% Solution
Baxter Healthcare Corp (Deerfield,Ill) recently received FDA approval forFlexbumin [Albumin (Human)] 25%Solution, the first preparation of humanalbumin to be packaged in a flexible container.The product has the same indicationsand provides the same stability asalbumin in glass bottles but providesimproved convenience for health careprofessionals, as its flexible packagingprovides less risk of breakage and ismore compatible with hospital inventorystorage systems. The flexible containersare lighter and require less space, whichmay save hospitals money on disposal.Flexbumin is a sterile, nonpyrogenicpreparation of albumin in a single dosageform for intravenous administration. Theproduct is indicated for the treatment ofhypovolemia, hypoalbuminemia due toinadequate reproduction, excessivecatabolism, hemorrhage, major surgeryor burns, and for use during cardiopulmonarybypass surgery. Flexbumin isavailable in 50- and 100-mL flexible containers.For more information, visitwww.baxter.com, or call 800-422-9837.
Articles in this issue
over 20 years ago
Should Pharmacists Receive Overtime Pay?over 20 years ago
Pharmacists—Cops or Not? (Part 2)over 20 years ago
canyouREADtheseRxs?over 20 years ago
compoundingHOTLINEover 20 years ago
NSAIDs and Antihypertensive Agentsover 20 years ago
FDA Approves New Constipation Drugover 20 years ago
Angina Drug Approvedover 20 years ago
Pancreatic Cancer Trials Offer Positive Resultsover 20 years ago
Cancer Drug Receives Approval for 2 Conditionsover 20 years ago
Long-term LNG/EE Use Does Not Hinder Future Ovulation










































































































